The past six months have been a windfall for Biogen’s shareholders. The company’s stock price has jumped 41.7%, setting a new ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on January 8. Truist lifted the price target on the stock to ...

Biogen (NASDAQ:BIIB) said its preliminary adjusted earnings per share for the fourth quarter of 2025 are expected to be about ...

Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated a ‘Neutral’ rating on the stock and raised the price target to $130 from ...

Biogen (NASDAQ:BIIB) is gearing up to announce its quarterly earnings on Thursday, 2025-10-30. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...

Biogen Inc. (NASDAQ:BIIB – Free Report) – Analysts at Wedbush boosted their Q2 2025 EPS estimates for shares of Biogen in a research note issued on Tuesday, July 15th. Wedbush analyst L. Chico now ...

Members of Congress have traded $BIIB stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales. Here’s a breakdown of recent ...

Florida-based J. L. Bainbridge sold 119,376 shares of Biogen for an estimated $16.1 million in the third quarter. After the transaction, J. L. Bainbridge reported holding just 2,969 shares of Biogen ...

Shares of Biogen BIIB gained 9.5% on Dec 29 following news on its potential acquisition by the South-Korean conglomerate Samsung Group. Per an article in The Korean Economic Daily, the U.S.-based ...